199 related articles for article (PubMed ID: 25688503)
1. The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7th Meeting of AIRO--Young Members Working Group (AIRO Giovani).
Franco P; De Bari B; Ciammella P; Fiorentino A; Chiesa S; Amelio D; Pinzi V; Bonomo P; Vagge S; Fiore M; Comito T; Cecconi A; Mortellaro G; Bruni A; Trovò M; Filippi AR; Greto D; Alongi F;
Tumori; 2014; 100(6):e214-9. PubMed ID: 25688503
[TBL] [Abstract][Full Text] [Related]
2. Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting.
Franco P; Fiorentino A; Dionisi F; Fiore M; Chiesa S; Vagge S; Cellini F; Caravatta L; Tombolini M; De Rose F; Meattini I; Mortellaro G; Apicella G; Marino L; Greto D
Tumori; 2016 Oct; 102(5):459-471. PubMed ID: 27514316
[TBL] [Abstract][Full Text] [Related]
3. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
4. A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial).
Mercier C; Dirix P; Meijnders P; Vermeulen P; Van Laere S; Debois H; Huget P; Verellen D
Radiat Oncol; 2018 Aug; 13(1):152. PubMed ID: 30126440
[TBL] [Abstract][Full Text] [Related]
5. Best of the Radiosurgery Society® Scientific Meeting 2014: stereotactic radiosurgery/stereotactic body radiotherapy treatment of extracranial and intracranial lesions.
Mahadevan A; Bucholz R; Gaya AM; Kresl JJ; Mantz C; Minnich DJ; Muacevic A; Medbery C; Yang J; Caglar HB; Davis JN
Future Oncol; 2014 Dec; 10(15):2307-10. PubMed ID: 25525840
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting.
De Bari B; Fiorentino A; Greto D; Ciammella P; Arcangeli S; Avuzzi B; D'Angelillo RM; Desideri I; Kirienko M; Marchiori D; Massari F; Fundoni C; Franco P; Filippi AR; Alongi F
Tumori; 2013; 99(6):637-49. PubMed ID: 24503785
[TBL] [Abstract][Full Text] [Related]
7. [Current indications and ongoing clinical trials with CyberKnife stereotactic radiotherapy in France in 2009].
Thariat J; Li G; Angellier G; Marchal S; Palamini G; Rucka G; Bénézery K; Castelli J; Trimaud R; Mammar H; Marcie S; Gérard JP; Bondiau PY
Bull Cancer; 2009 Sep; 96(9):853-64. PubMed ID: 19736172
[TBL] [Abstract][Full Text] [Related]
8. A strategy for young members within national radiation oncology societies: the Italian experience (AIRO Giovani group).
Filippi AR; Alongi F; Ciammella P; De Bari B; Franco P; Livi L
Rep Pract Oncol Radiother; 2012 Sep; 17(5):259-61. PubMed ID: 24669305
[TBL] [Abstract][Full Text] [Related]
9. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy.
Milano MT; Katz AW; Schell MC; Philip A; Okunieff P
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1516-22. PubMed ID: 18495378
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy for oligometastases.
Lo SS; Fakiris AJ; Teh BS; Cardenes HR; Henderson MA; Forquer JA; Papiez L; McGarry RC; Wang JZ; Li K; Mayr NA; Timmerman RD
Expert Rev Anticancer Ther; 2009 May; 9(5):621-35. PubMed ID: 19445579
[TBL] [Abstract][Full Text] [Related]
11. CyberKnife Stereotactic Ablative Radiotherapy as an Option of Treatment for Patients With Prostate Cancer Having Oligometastatic Lymph Nodes: Single-Center Study Outcome Evaluation.
Napieralska A; Miszczyk L; Stąpór-Fudzińska M
Technol Cancer Res Treat; 2016 Oct; 15(5):661-73. PubMed ID: 26208835
[TBL] [Abstract][Full Text] [Related]
12. Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO).
D'Angelillo RM; Francolini G; Ingrosso G; Ravo V; Triggiani L; Magli A; Mazzeo E; Arcangeli S; Alongi F; Jereczek-Fossa BA; Pergolizzi S; Pappagallo GL; Magrini SM
Crit Rev Oncol Hematol; 2019 Jun; 138():24-28. PubMed ID: 31092381
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic results of the treatment brain tumors using radiosurgery and stereotactic radiotherapy].
Doleželová H; Hynková L; Pospíšil P; Kazda T; Slampa P; Coupková I; Siková I; Fardus P; Svoboda T; Garčic J; Vrzal M; Selingerová I; Horová I
Klin Onkol; 2012; 25(6):445-51. PubMed ID: 23301647
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials of stereotactic ablative radiotherapy for prostate cancer: updates and future direction.
Musunuru HB; Loblaw A
Future Oncol; 2015; 11(5):819-31. PubMed ID: 25757684
[TBL] [Abstract][Full Text] [Related]
15. [NOVEL STRATEGY IN THE RADIOTHERAPY OF METASTATIC BRAIN TUMORS: SIMULTANEOUS WHOLE BRAIN RADIOTHERAPY AND INTEGRATED STEREOTACTIC RADIOSURGERY].
Kalincsák J; László Z; Sebestyén Z; Kovács P; Horváth Z; Dóczi T; Mangel László
Ideggyogy Sz; 2015 Nov; 68(11-12):391-7. PubMed ID: 26821513
[TBL] [Abstract][Full Text] [Related]
16. Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies.
De Bari B; Filippi AR; Mazzola R; Bonomo P; Trovò M; Livi L; Alongi F
Cancer Treat Rev; 2015 Jun; 41(6):511-8. PubMed ID: 25913714
[TBL] [Abstract][Full Text] [Related]
17. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
Timmerman RD; Fernando HC
Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Radiosurgery for Treatment of Brain Metastases.
Badiyan SN; Regine WF; Mehta M
J Oncol Pract; 2016 Aug; 12(8):703-12. PubMed ID: 27511715
[TBL] [Abstract][Full Text] [Related]
19. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
Radwan N; Phillips R; Ross A; Rowe SP; Gorin MA; Antonarakis ES; Deville C; Greco S; Denmeade S; Paller C; Song DY; Diehn M; Wang H; Carducci M; Pienta KJ; Pomper MG; DeWeese TL; Dicker A; Eisenberger M; Tran PT
BMC Cancer; 2017 Jun; 17(1):453. PubMed ID: 28662647
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review.
Kothari G; Foroudi F; Gill S; Corcoran NM; Siva S
Acta Oncol; 2015 Feb; 54(2):148-57. PubMed ID: 25140860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
